Marcos Arrut
CEO and Aging Researcher
Marcos Arrut is an Aging Researcher and CEO of RenovaCode Therapeutics, a biotechnology startup dedicated to advancing anti-aging medicine.
As a researcher specializing in biogerontology, his focus is on studying aging as a genetic program, the execution of which is mediated by dynamic changes in the epigenome. His work seeks to decipher and reverse these cellular mechanisms to alter the current paradigm of human longevity.